We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+11.61%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$134B
AUM Growth
+$7.76B
(+6.1%)
Cap. Flow
-$3.12B
Cap. Flow
% of AUM
-2.33%
Top 10 Holdings %
Top 10 Hldgs %
37.24%
Holding
340
New
6
Increased
106
Reduced
171
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nextpower Inc
NXT
|
+$384M |
| 2 |
ConocoPhillips
COP
|
+$313M |
| 3 |
Alibaba
BABA
|
+$188M |
| 4 |
JPMorgan Chase
JPM
|
+$113M |
| 5 |
Wolfspeed
WOLF
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$1.65B |
| 2 |
Eli Lilly
LLY
|
+$673M |
| 3 |
Flex
FLEX
|
+$371M |
| 4 |
Abbott
ABT
|
+$220M |
| 5 |
NVIDIA
NVDA
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.32% |
| 2 | Technology | 31.25% |
| 3 | Industrials | 11.52% |
| 4 | Consumer Discretionary | 8.02% |
| 5 | Financials | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZIMV
326
DELISTED
ZimVie
ZIMV
| $668K | ﹤0.01% |
40,510
| – | – |
|
327
Bloom Energy
BE
$51.5B
| $558K | ﹤0.01% |
49,600
| – | – |
|
328
Bioceres Crop Solutions
BIOX
$21.6M
| $503K | ﹤0.01% |
39,700
| – | – |
|
329
Adaptive Biotechnologies
ADPT
$3.56B
| $469K | ﹤0.01% |
146,190
| – | – |
|
330
Accuray
ARAY
$27.2M
| $439K | ﹤0.01% |
177,700
-1,500
| -0.8% | -$4.02K |
|
|
VLRS
331
Controladora Vuela Compania de Aviacion
VLRS
$897M
| $391K | ﹤0.01% |
52,700
| – | – |
|
332
908 Devices
MASS
$288M
| $203K | ﹤0.01% |
26,870
| – | – |
|
|
MREO
333
Mereo BioPharma
MREO
$50.1M
| $178K | ﹤0.01% |
54,000
| – | – |
|
|
SAVE
334
DELISTED
Spirit Airlines, Inc.
SAVE
| $110K | ﹤0.01% |
22,700
-400
| -2% | -$2.96K |
|
335
Amylyx Pharmaceuticals
AMLX
$2.04B
| $28.4K | ﹤0.01% |
10,000
-146,900
| -94% | -$1.92M |
|
336
Hilton Worldwide
HLT
$74.6B
| – | – |
-563,565
| Closed | -$103M |
|
337
Nice
NICE
$5.59B
| – | – |
-50,250
| Closed | -$10M |
|
|
SAGE
338
DELISTED
Sage Therapeutics
SAGE
| – | – |
-74,950
| Closed | -$1.62M |
|
|
SPLK
339
DELISTED
Splunk Inc
SPLK
| – | – |
-10,820,268
| Closed | -$1.65B |
|
|
IMGN
340
DELISTED
Immunogen Inc
IMGN
| – | – |
-273,100
| Closed | -$8.1M |
|
Similar funds
Primecap Management's Q1 2024 Portfolio in Review
As of Q1 2024, Primecap Management held 340 positions worth $134B, up 6.1% from $126B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.2%. Primecap Management opened 6 new positions and exited 5, leaving the 340-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.
- Primecap Management's largest Q1 2024 buy was ConocoPhillips: 2,746,355 shares worth $350M.
- Primecap Management added most to Nextpower Inc in Q1 2024, an estimated $384M increase.
- Primecap Management's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $673M.
- Primecap Management fully exited Splunk Inc in Q1 2024, selling an estimated $1.65B.
- Primecap Management's ten largest holdings make up 37% of its $134B portfolio in Q1 2024.
- Primecap Management opened 6 new positions and closed 5 in Q1 2024.
- Primecap Management's portfolio value rose 6.1% quarter-over-quarter to $134B.
Based on Primecap Management's 13F filing for Q1 2024, filed 14 May 2024.